Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Standard Precaution01:26

Standard Precaution

1.9K
Standard precautions are the minimum infection control safeguards used while caring for all patients, irrespective of their disease condition. They help prevent the spread of common infectious microorganisms to healthcare workers, patients, and visitors in all healthcare settings.
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
1.9K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Monitoring of the Cascade of Care in Patients With Chronic HBV in Primary Care Clinics in Australia.

Journal of viral hepatitis·2026
Same author

A Distinct Immune Signature Characterizes Cirrhosis in Ethiopian Individuals With Chronic HBV Infection.

Alimentary pharmacology & therapeutics·2026
Same author

Health-related Quality of Life in Patients With Chronic Hepatitis B and Liver-Related Complications in The Gambia.

Value in health regional issues·2026
Same author

Field performance and acceptability of the hepatitis B core-related antigen rapid diagnostic test (HBcrAg-RDT) for detecting high viral load among pregnant women in The Gambia (PROTECT-B).

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Elimination in the age of retrenchment: what hepatitis reveals about the future of global health.

The Lancet. Global health·2026
Same author

Hepatic flares, their immune signatures, and ALT variability after nucleos(t)ide analogue cessation in HBeAg-negative hepatitis B.

JHEP reports : innovation in hepatology·2026

相关实验视频

Updated: Jun 24, 2025

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection
04:11

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection

Published on: December 15, 2023

3.3K

乙型肝炎歧视:全球应对需要全球数据

Catherine Freeland1, Anousha Qureshi2, Jack Wallace3,4,5

  • 1Hepatitis B Foundation, Doylestown, PA, USA. Freeland@hepb.org.

BMC public health
|June 11, 2024
PubMed
概括

对慢性乙型肝炎 (CHB) 患者的歧视是普遍存在的,影响了工作,教育和情感福祉. 解决这种耻辱对于实现全球乙型肝炎消除目标至关重要.

关键词:
没有歧视的歧视.乙型肝炎 B 型肝炎肝癌是一种肝癌.肝脏疾病是一种肝脏疾病.污名化是一种耻辱.病毒性肝炎的病毒性肝炎.

更多相关视频

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
10:37

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Published on: October 20, 2021

2.9K
Multicellular Human Alveolar Model Composed of Epithelial Cells and Primary Immune Cells for Hazard Assessment
09:27

Multicellular Human Alveolar Model Composed of Epithelial Cells and Primary Immune Cells for Hazard Assessment

Published on: May 6, 2020

11.3K

相关实验视频

Last Updated: Jun 24, 2025

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection
04:11

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection

Published on: December 15, 2023

3.3K
Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
10:37

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Published on: October 20, 2021

2.9K
Multicellular Human Alveolar Model Composed of Epithelial Cells and Primary Immune Cells for Hazard Assessment
09:27

Multicellular Human Alveolar Model Composed of Epithelial Cells and Primary Immune Cells for Hazard Assessment

Published on: May 6, 2020

11.3K

科学领域:

  • 肝病学 肝病学是一种肝病学.
  • 公共卫生 公共卫生
  • 社会科学 社会科学 社会科学

背景情况:

  • 全球有超过2.5亿人患有慢性乙型肝炎 (CHB).
  • 基于乙型肝炎状态的歧视是一个重要的,但没有充分记录的问题.
  • 这种歧视可以表现为不公正或有偏见的待遇.

研究的目的:

  • 描述患有CHB的个人的歧视经历.
  • 记录乙型肝炎相关歧视的影响和后果.
  • 提供数据支持对抗乙型肝炎的干预措施的需要.

主要方法:

  • 建立了一个全球乙型肝炎歧视注册表,以收集自我报告的数据.
  • 该注册表包括人口统计,歧视事件和开放式体验问题.
  • 从2021年5月到2023年12月,通过患者网络和社交媒体收集数据.

主要成果:

  • 来自65个国家的569个人回应了; 461个详细的歧视经历.
  • 歧视的常见形式包括工作签证限制,就业障碍和教育歧视.
  • 还报告了情绪困扰和社区/医疗保健歧视.

结论:

  • 不论症状如何,乙型肝炎的歧视都会对个人的生活和经济机会产生重大影响.
  • 歧视是诊断和护理的障碍,阻碍了消除乙型肝炎的努力.
  • 需要全球和国家战略来解决与乙型肝炎相关的歧视问题.